Coronavirus Latest News

Shanghai’s Fosun Pharma inks agreement to supply 10 million doses of Covid-19 vaccine to Hong Kong and Macau once approved

Shanghai Fosun Pharmaceutical (Group), which aims to bring German partner BioNTech’s coronavirus vaccine to China by the end of the year, has inked an agreement with a distributor to potentially supply 10 million doses to Hong Kong and Macau.“Fosun Pharma and BioNTech have signed a letter of intent with a distributor for the supply of 10 million doses of the Covid-19 vaccine to Hong Kong and Macau, upon its clinical trial results being approved by regulators,” Fosun said in a statement late on…

Read the original article at South China Morning Post

Related Articles